Clinical Trial Update: Sirolimus for the Treatment of Hyperinsulinism [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating sirolimus for hyperinsulinism (Phase 1/2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinism

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Hyperinsulinism | Phase 1, Phase 2 | Status: WITHDRAWN